JACOBS LEVY EQUITY MANAGEMENT, INC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$182,711
-40.6%
11,586
+10.0%
0.00%
-50.0%
Q4 2022$307,822
-64.0%
10,531
-67.5%
0.00%
-71.4%
Q3 2022$855,000
-30.8%
32,377
+16.5%
0.01%
-30.0%
Q2 2022$1,235,000
-74.2%
27,793
-71.3%
0.01%
-68.8%
Q1 2022$4,795,000
-34.0%
96,890
-32.1%
0.03%
-34.7%
Q4 2021$7,266,000
-20.1%
142,692
-12.5%
0.05%
-19.7%
Q3 2021$9,098,000
+23.7%
163,099
-5.1%
0.06%
+22.0%
Q2 2021$7,355,000
+11.5%
171,840
+8.8%
0.05%
-2.0%
Q1 2021$6,595,000
-8.7%
158,005
+1.9%
0.05%
-19.0%
Q4 2020$7,222,000
+26.8%
155,070
+15.7%
0.06%
+6.8%
Q3 2020$5,696,000
+26.8%
134,076
+43.2%
0.06%
+20.4%
Q2 2020$4,492,000
+54.4%
93,630
+48.1%
0.05%
+32.4%
Q1 2020$2,909,000
+132.2%
63,241
+203.2%
0.04%
+208.3%
Q4 2019$1,253,000
+31.6%
20,860
+23.9%
0.01%0.0%
Q3 2019$952,000
+5.2%
16,836
+3.6%
0.01%
-7.7%
Q2 2019$905,00016,2460.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders